Biotech

Latest Articles

Former Seagen chief executive officer unveils brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer last year for a monstrous $...

Ironwood makes more bid for $1B GI drug along with brand new subgroup data

.On the heels of a phase 3 gain that fell short to thrill real estate investors, Ironwood Pharmaceut...

Novartis inks $150M package for autoimmune molecular glue

.Do not quit Monte Rosa Therapeutics currently. The Boston-based biotech is having a ball after auth...

Jade takes exec crew with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable management hirings, firings and also...

Septerna goes social along with upsized offering of $288M

.Commemorating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fi...

AbbVie makes Richter richer, paying $25M to form discovery treaty

.AbbVie has actually returned to the source of its own antipsychotic powerhouse Vraylar searching fo...

GenSight goes into final weeks of money runway as profits flow edges out of range

.GenSight Biologics is full weeks away from losing money. Again. The biotech simply has adequate cas...

AZ licenses disposed of rare ailment medicine to Monopar Therapies

.Monopar Therapies is actually recouping a medication from the scrap heap of AstraZeneca's rare cond...

Arcus' brand new HIF-2a data in renal cancer cells mention potential advantage over Merck's Welireg, professionals say

.With brand new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of exp...

Roche wagers as much as $1B to grow Dyno gene treatment shipping treaty

.After developing a genetics treatment alliance along with Dyno Therapeutics in 2020, Roche is back ...

Lundbeck slashes market value of $250M Abide buyout after discomfort misfortune

.Lundbeck is actually lowering the book value of its $250 thousand Abide Therapeutics purchase in ac...

Real- Globe Information Satisfies Clinical Trial Concept: Enhancing Methods and Internet Site Option

.The integration of real-world data (RWD) in to protocol workability and internet site collection ha...

Where are they today? Overtaking previous Brutal 15 guest of honors

.At this year's Strong Biotech Top in Boston ma, our company caught up with leaders in the biotech s...

Merck snaps up preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is putting down $30 thousand upfront to purchase Yale spinout Modifi Biosciences, an...

Radiopharma Alpha-9 increases $175M set C to cash medical press

.Alpha-9 Oncology has increased a $175 thousand collection C cycle to stake its own clinical-stage r...

Ocuphire to transform right into gene therapy biotech via Opus purchase

.Eye medicine maker Ocuphire Pharma is acquiring genetics therapy developer Piece Genes in an all-st...

Roche culls hack candidate, pivots KRAS course in Q3 update

.Roche's persistent coughing course has actually sputtered to a stop. The drugmaker, which axed the ...

Merck- Gilead long-acting dental combination reduces HIV for 48 weeks

.Gilead Sciences and also Merck &amp Co. have helped their once-weekly HIV mixture treatment past ye...

Lykos accepts FDA view that MDMA authorization relies on fresh trial

.Lykos Therapeutics might possess shed three-quarters of its own personnel in the wake of the FDA's ...

Septerna considers $158M IPO to fund readouts for GPCR pipeline

.Septerna may be actually yet to disclose "any sort of meaningful professional information," but the...